Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and Adolescents
Conditions
Polyarticular Course Juvenile Idiopathic Arthritis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UZ Leuven, Leuven, Belgium
Contact: Study coordinator (Lien De Somer)Vseobecna fakultni nemocnice v Praze, Prague, Czechia
Contact: Study coordinator (Pavla Dolezalova)Hôpital Bicêtre, Le Kremlin-Bicêtre, France
Contact: Study coordinator (Isabelle Kone-Paut)Charité - Campus Virchow-Klinikum, Berlin, Germany
Contact: Study coordinator (Kirsten Minden)Hamburger Zentrum fuer Kinder und Jugendrheumatologie, Hamburg, Germany
Contact: Study coordinator (Ivan Foeldvari)Pecsi Tudomanyegyetem Klinikai Kozpont, Pécs, Hungary
Contact: Study coordinator (Bernadett Mosdosi)Istituto Giannina Gaslini-Ospedale Pediatrico IRCCS, Genova, Italy
Contact: Study coordinator (Alessandro Consolaro)Centrum Medyczne Hipokrates S C Elzbieta I Grzegorz Grzesk, Bydgoszcz, Poland
Contact: Study coordinator (Elzbieta Grzesk)MICS Centrum Medyczne Torun, Torun, Poland
Contact: Study coordinator (Slawomir Jeka)ETG JustMed, Warsaw, Poland
Contact: Study coordinator (Marta Szwarc Bronikowska)Hospital Sant Joan de Deu, Barcelona, Spain
Contact: Study coordinator (Jordi Anton Lopez)Bristol Royal Hospital for Children, Bristol, United Kingdom
Contact: Study coordinator (Athimalaipet Ramanan)Leicester Royal Infirmary, Leicester, United Kingdom
Contact: Study coordinator (Khulood Khawaja)Nottingham University Hospitals Queen's Medical Centre, Nottingham, United Kingdom
Contact: Study coordinator (Satyapal Rangaraj)
Study leads
Catherine Vincent
Study Director
Alfasigma S.p.A.